Expansion of clonotypic T-cell populations in the peripheral blood of asymptomatic Gran Chaco Amerindians infected with HTLV-IIB

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 18, Issue 2, 1998, Pages 178-185

  Love, Jayne L ^a   Marchioli, Carmine C ^a   Dube, Syamalima ^a   Bryz Gornia, Virginia ^a   Loughran Jr , Thomas P ^a   Glaser, Jordan B ^b   Esteban, Eduardo ^c   Feldman, Leonardo ^c   Ferrer, Jorge F ^d   Poiesz, Bernard J ^a,e  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b STATEN ISLAND UNIVERSITY HOSPITAL   (United States)

^c UNIVERSIDAD NACIONAL DEL CENTRO DE LA PROVINCIA DE BUENOS AIRES   (Argentina)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

Gran Chaco Amerindians; HTLV IIB; Peripheral blood mononuclear cells (PBMC); Polymerase chain reaction (PCR); T cell receptor; V gene rearrangement

Indexed keywords

T LYMPHOCYTE RECEPTOR;

AMERICAN INDIAN; ARTICLE; CLINICAL ARTICLE; CLONE; CONTROLLED STUDY; GENE REARRANGEMENT; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 2; HUMAN T CELL LEUKEMIA VIRUS INFECTION; MONONUCLEAR CELL; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; T LYMPHOCYTE;

CHACO; HTLV; HTLV II; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE 2B;

EID: 13144297197     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199806010-00010     Document Type: Article

References (45)

1. Merl S, Kloster B, Moore J, et al. Efficient transformation of previously activated and dividing T lymphocytes by human T-cell leukemia/lymphoma virus. Blood 1984;64:967.
2. Chen ISY, Quan SG, Golde DW. Human T-cell leukemia virus type II transforms normal human lymphocytes. Proc Natl Acad Sci USA 1983;80:7006.
3. + lymphocytosis in a patient doubly infected with HTLV-I and HIV-1: a clinical and molecular analysis. Am J Hematol 1989;30: 128.
4. Ijichi S, Ramundo M, Jakahashi H, Kaplan M, Hall W. In vivo cellular tropism of human T-cell leukemia virus, type II (HTLV-II). J Exp Med 1992;176:293.
5. + cells. Virology 1995;210:441.
6. Greene WC, Bohnlein E, Bullard DW. HIV-1, HTLV-I and normal T-cell growth: transcriptional strategies and surprises. Immunol Today 1989;10:272.
7. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type-C retrovirus particles from fresh and cultured T-lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980;77:7415.
8. Gessain A, Barin F, Vernant JC, et al. Antibodies to human T-lymphotropic virus type I in patients with tropical spastic paraparesis. Lancet 1985;2:407.
9. Bhagavati S, Ehrlich G, Kula RW, Kwok S, Sninsky J, Poiesz BJ. Detection of human T-cell lymphoma/leukemia virus type I DNA and antigen in spinal fluid and blood of patients with chronic progressive myelopathy. N Engl J Med 1988;318:1141.
10. Sherman MP, Amin RM, Rodgers-Johnson PEB, et al. Identification of human T cell leukemia/lymphoma virus type I antibodies, DNA, and protein in patients with polymyositis. Arthritis Rheum 1995;38:690.
11. Kitajima I, Yamamoto K, Sato K. Detection of human T-cell leukemia/lymphoma virus type I proviral DNA and its gene expression in synovial cells in chronic inflammatory arthropathy. J Clin Invest 1991;88:1315.
12. Mochizuki M, Watanabe T, Yamaguchi K. HTLV-I uveitis: a distinct clinical entity caused by HTLV-I. Jpn J Cancer Res 1992; 83:236.
13. Kondo T, Nonaka H, Miyamoto N, et al. Incidence of Adult T-cell leukemia-lymphoma and its familial clustering. Int J Cancer 1985; 35:749.
14. Murphy EL, Hanchard B, Figuero JP, et al. Modelling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I. Int J Cancer 1989;43:250.
15. Kalyanaraman VS, Sarangadaharan MG, Miyoshi I, Blayney D, Golde D, Gallo RC. A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Science 1982;218:571.
16. + T cells from a patient with "atypical" hairy cell leukemia. Evidence for distinct T and B cell lymphoproliferation disorders. Blood 1988;71:363.
17. Loughran TP, Coyle T, Sherman MP, Starkbaum G, et al. Detection of human T-cell leukemia/lymphoma virus type II in a patient with LGL leukemia. Blood 1992;80:1116.
18. Zucker-Franklin D, Hooper WC, Evatt BL. Human lymphotropic retroviruses associated with mycosis fungoides and evidence that human T-cell lymphotropic virus type II (HTLV-II) as well as HTLV-I may play a role in the disease. Blood 1992;80:1537.
19. Hjelle B, Apenzeller O, Mills R, et al. Chronic neurodegenerative disease associated with HTLV-II infection. Lancet 1992;339:645.
20. Harrington WJ, Sheremata B, Hjelle B, et al. Spastic ataxia associated with HTLV-II infection. Ann Neurol 1993;33:411.
21. Jacobsen S, Lehky T, Nishimura M, Robinson S, McFarlin DE, Dhib-Jallent S. Isolation of HTLV-II from a patient with chronic progressive neurological disease clinically indistinguishable from HTLV-I associated myelopathy tropical spastic paraparesis. Ann Neurol 1993;33:392.
22. Sheremata W, Harrington W Jr, Bradshaw P, et al. Association of "tropical ataxic neuropathy" with HTLV-II. Virus Res 1993;29: 77.
23. Ferrer JF, Esteban E, Dube S, et al. Endemic infection with human T cell leukemia/lymphoma virus type IIB in Argentinian and Paraguayan Indians: epidemiology and molecular characterization. J Infect Dis 1996;174:944.
24. Griesser H, Mak TW. The T-cell receptor-structure, function, and clinical application. Hematol Pathol 1994;8:1.
25. Gill JI, Gulley ML. Immunoglobulin and T-cell receptor gene rearrangement. Diag Hematol 1994;8:751.
26. Beers T, Du T-L, Rickert M, Overturf P, Choi Y, Greenberg S. Ex vivo clonotype primer-directed gene amplification to identify malignant T-cell repertoires. J Leukoc Biol 1993;54:343.
27. + T cell population of rheumatoid arthritis patients. J Immunol 1996;156:852.
28. Dube DK, Sherman MP, Saksena NK, et al. Genetic heterogeneity in human T-cell leukemia/lymphoma virus type II. J Virol 1993; 67:1175.
29. Iannone R, Sherman MP, Rodgers-Johnson PEB, et al. HTLV-I DNA sequences in central nervous system tissue of a patient with tropical spastic paraparesis and HTLV-I associated myelopathy. J Acquir Immune Defic Syndr 1992;5:810.
30. Poiesz BJ, Dube S, Jones B, et al. Comparative performances of enzyme-linked immunosorbent, Western blot and polymerase chain reaction assays for human T-cell lymphoma/leukemia virus type II infection that is endemic among Indians of the Gran Chaco region of South America. Transfusion 1997;37:52.
31. Sharkey DJ, Scalice ER, Christy Jr KG, Atwood SM, Daiss SM. Antibodies as thermolabile switches: high temperature triggering for the polymerase chain reaction. Bio/Technology 1994;12:506.
32. Longo MC, Beminger MS, Hartley JL. Use of uracil DNA glycosylase to control carryover contamination in polymerase chain reaction. Gene 1990;93:125.
33. Tarella C, Ruscetti FW, Poiesz BJ, Woods A, Gallo RC. Factors that affect human hematopoiesis are produced by T-cell growth factor dependent and independent cultured T-cell leukemia/ lymphoma cells. Blood 1982;59:1330.
34. Loughran TP. Clonal diseases of large granular lymphocytes. Blood 1993;82:1.
35. + leukemic large granular lymphocytes utilize diverse T-cell receptor VB genes. Blood 1995;85:146.
36. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977;74:5463.
37. Gustaffson TL. EPISTAT. Round Rock, TX: 1985.
38. Davey F, Henry JB. Basic examination of blood. In Henry JB, ed. Clinical diagnosis and management by laboratory methods. Philadelphia: WB Saunders, 1996:549.
39. Yoshida M, Seiki M, Yamaguchi K, Takatsuki K. Monoclonal integration of HTLV in primary tumors of adult t-cell leukemia suggests a causative role of HTLV in the disease. Proc Natl Acad Sci USA 1984;81:2534.
40. Furukawa Y, Fujisawa J, Osame M, et al. Frequent clonal proliferation of human T-cell leukemia virus type 1 (HTLV)-infected T cells in HTLV-I associated myelopathy (HAM-TSP). Blood 1992; 80:1012.
41. + cytotoxic T lymphocytes against human T cell lymphotropic virus type I (HTLV-I) genome products in HTLV-I-associated myelopathy tropical spastic paraparesis patients. J Clin Invest 1994;94: 1830.
42. Sherman MP, Dube S, Dube D, Poiesz BJ. Virally infected T- cell malignancies and associated states. In Rich RR, Fleisher TA, Schwartz BD, Shearer WT, Strober W, eds. Clinical immunology: principles and practice, vol. 2. St. Louis: CV Mosby, 1995:1785.
43. Wattel E, Vartanian JP, Pannetier C, Wain-Hobson S. Clonal expansion of human T-cell leukemia virus type I-infected cells in asymptomatic and symptomatic carriers with malignancy. J Virol 1995;69:2863.
44. Cavrois M, Gessain A, Wain-Hobson S, Wattel E. Proliferation of HTLV-I infected circulating cells in vivo in all asymptomatic carriers and patients with TSP/HAM. Oncogene 1996;12:2419.
45. Cimarelli A, Duclos CA, Gessain A, Casoli C, Bertazzoni V. Clonal expansion of human T-cell leukemia virus type II in patients with high proviral load. Virology 1996;223:362.